1,425
Participants
Start Date
June 14, 2021
Primary Completion Date
May 13, 2022
Study Completion Date
May 13, 2022
20vPnC
20vPnC
Saline
Saline
13vPnC
Pneumococcal conjugate vaccine
PPSV23
Pneumococcal polysaccharide vaccine
Far Eastern Memorial Hospital, New Taipei City
Linkou Chang Gung Memorial Hospital, Taoyuan
National Cheng Kung University Hospital, Tainan City
National Taiwan University Hospital, Taipei
Korea University Ansan Hospital, Ansan-si
The Catholic University of Korea, St. Vincent's Hospital, Suwon
Ajou University Hospital, Suwon
Inha University Hospital, Incheon
Taipei Medical University Shuang Ho Hospital, New Taipei City
China Medical University Hospital, Taichung
Kyungpook National University Hospital, Daegu
Hillside Clinic Jingumae, Shibuya-ku
P-one Clinic, Keikokai Medical Corporation, Hachioji-shi
Seishinkai Inoue Hospital, Itoshima
Women's Clinic LUNA NEXT STAGE, Naka-ku, Yokohama-Shi
Medical Corporation Heishinkai OPHAC Hospital, Osaka
Medical Corporation Heishinkai OCROM Clinic, Suita-shi
Nihonbashi Sakura Clinic, Chuo-ku
Fukuwa Clinic, Chuo-ku
Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku
SOUSEIKAI PS Clinic, Fukuoka
Korea University Guro Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Kangdong Sacred Heart Hospital, Seoul
Asan medical Center, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Hallym University Kangnam Sacred Heart Hospital, Seoul
Ewha Womans University Mokdong Hospital, Seoul
Lead Sponsor
Pfizer
INDUSTRY